Organovo Gross Profit from 2010 to 2024
| ONVO Stock | USD 0.43 0.01 2.38% |
Gross Profit | First Reported 2011-09-30 | Previous Quarter -33 K | Current Value 29 K | Quarterly Volatility 386.4 K |
Check Organovo Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organovo Holdings' main balance sheet or income statement drivers, such as Depreciation And Amortization of 517.7 K, Interest Expense of 531.1 K or Selling General Administrative of 14.1 M, as well as many indicators such as Price To Sales Ratio of 145, Dividend Yield of 0.0 or Days Sales Outstanding of 49.4. Organovo financial statements analysis is a perfect complement when working with Organovo Holdings Valuation or Volatility modules.
Organovo | Gross Profit |
Latest Organovo Holdings' Gross Profit Growth Pattern
Below is the plot of the Gross Profit of Organovo Holdings over the last few years. Gross profit is a required income statement account that reflects total revenue of Organovo Holdings minus its cost of goods sold. It is profit before Organovo Holdings operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Organovo Holdings' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Organovo Holdings' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (8.52 M) | 10 Years Trend |
|
Gross Profit |
| Timeline |
Organovo Gross Profit Regression Statistics
| Arithmetic Mean | 1,217,370 | |
| Coefficient Of Variation | 95.63 | |
| Mean Deviation | 914,771 | |
| Median | 850,000 | |
| Standard Deviation | 1,164,137 | |
| Sample Variance | 1.4T | |
| Range | 3.6M | |
| R-Value | (0.18) | |
| Mean Square Error | 1.4T | |
| R-Squared | 0.03 | |
| Significance | 0.52 | |
| Slope | (46,736) | |
| Total Sum of Squares | 19T |
Organovo Gross Profit History
Other Fundumenentals of Organovo Holdings
Organovo Holdings Gross Profit component correlations
Click cells to compare fundamentals
About Organovo Holdings Financial Statements
Organovo Holdings investors utilize fundamental indicators, such as Gross Profit, to predict how Organovo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 109 K | 103.5 K | |
| Gross Profit Margin | (2.62) | (2.75) |
Pair Trading with Organovo Holdings
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organovo Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organovo Holdings will appreciate offsetting losses from the drop in the long position's value.Moving together with Organovo Stock
| 0.84 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.81 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.84 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Organovo Stock
| 0.85 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.74 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.43 | PHVS | Pharvaris BV | PairCorr |
| 0.39 | PMVP | Pmv Pharmaceuticals | PairCorr |
| 0.36 | ESLAW | Estrella Immunopharma | PairCorr |
The ability to find closely correlated positions to Organovo Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organovo Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organovo Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organovo Holdings to buy it.
The correlation of Organovo Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organovo Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organovo Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organovo Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Organovo Holdings Correlation against competitors. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.04) | Revenue Per Share 0.008 | Quarterly Revenue Growth (0.48) | Return On Assets (0.89) | Return On Equity (2.07) |
The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.